Tim Nutbeam: Women With Major Trauma Receive Less Care
Tim Nutbeam, Consultant in Emergency Medicine at University Hospitals Plymouth NHS Trust, shared a post on LinkedIn:
”Women with major trauma receive less care.
They are less likely to receive blood products.
Less likely to receive tranexamic acid.
Less likely to be taken to a trauma centre.
Less likely to be admitted to intensive care.
And they experience worse long-term outcomes – including higher rates of disability and poorer functional recovery.
We now have a clearer picture of why that matters.
Working with an excellent team including long term collaborator François-Xavier AGERON – proud to present this large international scoping review; looking across the trauma pathway, from prehospital care through to hospital treatment.
The signal is consistent and these differences are not fully explained by mechanism or severity.
They appear to be features of the system.
Not biology. Not evidence. The system.
This is difficult work.
Not because the data are unclear – but because the implications are.
The question now is not whether inequity exists.
It’s what we do about it.”

Stay updated with Hemostasis Today.
-
Aug 31, 2026, 15:44Andrea Boccatonda: Special Issue on Pulmonary Embolism and Venous Thromboembolism
-
Aug 31, 2026, 15:41Adrien Jossart: Acute Thrombotic Storm Following Single Heparin Bolus
-
Aug 31, 2026, 15:36Bernhard Gerber: Myocardial Platelet Activation Linked to Microvascular Obstruction After STEMI
-
Aug 31, 2026, 15:34Higher Fibrinogen γ′ Linked to Increased Risk of Recurrent Arterial Thrombosis – Journal of Thrombosis and Haemostasis
-
Aug 31, 2026, 15:21Ney Carter Borges: Anticoagulation Versus Antiplatelet Therapy After TAVI ESC 26
-
Aug 31, 2026, 15:13Nahid A. Qushmaq: MicroRNAs as Prognostic Biomarkers in Septic Patients
-
Aug 31, 2026, 14:32Mahir Khalil Ibrahim Jallo: Hot Topic From The ESC 2026 Munich
-
Aug 31, 2026, 14:28Ruben Mesa: FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
-
Aug 31, 2026, 14:28Francisco Chacón-Lozsán: Should We Anticoagulate AF Patients With Only One Non-Sex Stroke Risk Factor?